Zentalis Pharmaceuticals Inc.

ZNTL | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.03

-$0.08 (-2.57%)

At close: Sep 21, 2026, 4:00 PM ET

$3.08

+$0.05 (+1.64%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $221.39M

Enterprise Value $74.64M

Beta 1.86

Average Volume 1.13M

Shares Outstanding (Diluted) 70.26M

Shares Change YoY -2.4%

Institutional Ownership 57.40%

Exchange NASDAQ

ISIN US98943L1070

Price Performance

Price Change 1M -21.1%

Price Change 3M -17.7%

Price Change 6M 18.8%

Price Change YTD 121.2%

Price Change 1Y 99.3%

Price Change 3Y -85.8%

Price Change 5Y -95.1%

1M CAGR (ann.) -37.8%

1Y CAGR (ann.) 119.0%

5Y CAGR (ann.) -46.3%

All-Time CAGR -26.7%

Valuation

PE Ratio -1.23

Forward PE N/A

PEG Ratio 0.05

Forward PEG 0.15

PS Ratio N/A

Forward PS 20.00

PB Ratio 1.50

P/FCF Ratio -1.34

P/Adj. FCF Ratio -1.23

P/OCF Ratio -1.32

EV/Sales N/A

EV/EBIT -0.43

EV/EBITDA -0.43

EV/FCF -0.46

Earnings Yield -81.2%

FCF Yield -74.7%

Adj. FCF Yield -81.4%

Financial Health

Net Cash $141.05M

Total Debt $33.56M

Cash & Short-Term Investments $174.61M

Total Assets $215.33M

Current Ratio 4.82

Quick Ratio 4.82

Debt / Equity Ratio 0.26

Debt / EBITDA -0.19

Debt / FCF -0.21

OCF / Debt -4.80

Interest Coverage 0.00

Altman Z-Score -8.27

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -8.9%

Returns

Return on Assets -81.2%

Return on Equity -88.0%

Return on Invested Capital -105.2%

Return on Capital Employed -107.6%

Return on Tangible Assets -81.2%

Historical Growth (CAGR)

Revenue CAGR 3Y -90.2%

Revenue CAGR 5Y 19.9%

Revenue CAGR 10Y N/A

EPS CAGR 3Y 5.8%

EPS CAGR 5Y 15.3%

EPS CAGR 10Y N/A

FCF CAGR 3Y 1.8%

FCF CAGR 5Y 3.9%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 12

EPS Growth Next 3Y 18.3%

Revenue Growth Next 3Y N/A

Earnings Date N/A

EPS Estimate (next Q) N/A

EPS Growth Est (next Q) N/A

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $8.33

Price Target Upside 174.9%

Cash Flow

Operating Cash Flow $-161.05M

Free Cash Flow $-161.12M

Adj. Free Cash Flow $-175.48M

FCF Per Share -$2.29

OCF Per Share -$2.29

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-151K

Operating Income $-191.23M

EBITDA $-173.46M

Net Income $-174.9M

EPS (Diluted) -$2.46

Revenue / Employee N/A

Profit / Employee $-1.65M

Employees 106